Single agent oral vinorelbine (NVB) in advanced non-small cell lung cancer (NSCLC) in the elderly: Patient benefit improvement by weekly schedule

Autor:	Miklos Pless, Pekka Mali, F. De Marinis, J.-C. Pouget, C. Gridelli, O. Castelnau, Christian Manegold, D. Aubert, J.-P. Burillon
Rok vydání:	2004
Předmět:	Oncology Cancer Research medicine.medical_specialty Schedule business.industry non-small cell lung cancer (NSCLC) Vinorelbine medicine.disease stomatognathic diseases Reduced toxicity Internal medicine medicine Single agent Elderly patient business medicine.drug
Zdroj:	Journal of Clinical Oncology. 22:7120-7120
ISSN:	1527-7755 0732-183X
Popis:	7120 Background:Single agent IV NVB has proven its effectiveness in elderly NSCLC pts with reduced toxicity. IV and oral NVB formulation have proven comparable bioavailability. This phase II was co...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0a71591720a37db0bcbc578492e7ddae https://doi.org/10.1200/jco.2004.22.90140.7120 Zobrazit plný text záznamu